Study: NCT03982186

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-73763989
Description: JNJ-73763989 will be administered as medium dose (Arms 1 and 3), high dose (Arm 2), and low dose (Arm 4) as subcutaneous injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-73763989
Description: JNJ-73763989 will be administered as medium dose (Arms 1 and 3), high dose (Arm 2), and low dose (Arm 4) as subcutaneous injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-73763989
Description: JNJ-73763989 will be administered as medium dose (Arms 1 and 3), high dose (Arm 2), and low dose (Arm 4) as subcutaneous injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-73763989
Description: JNJ-73763989 will be administered as medium dose (Arms 1 and 3), high dose (Arm 2), and low dose (Arm 4) as subcutaneous injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for JNJ-73763989
Description: Placebo for JNJ-73763989 will be administered as subcutaneous injection.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for JNJ-73763989
Description: Placebo for JNJ-73763989 will be administered as subcutaneous injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: JNJ-56136379 tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: JNJ-56136379 tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for JNJ-56136379
Description: Placebo for JNJ-56136379 tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for JNJ-56136379
Description: Placebo for JNJ-56136379 tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for JNJ-56136379
Description: Placebo for JNJ-56136379 tablets will be administered orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for JNJ-56136379
Description: Placebo for JNJ-56136379 tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide Analog (NA)
Description: NA treatment that is either of ETV, TDF or TAF tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide Analog (NA)
Description: NA treatment that is either of ETV, TDF or TAF tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide Analog (NA)
Description: NA treatment that is either of ETV, TDF or TAF tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide Analog (NA)
Description: NA treatment that is either of ETV, TDF or TAF tablets will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide Analog (NA)
Description: NA treatment that is either of ETV, TDF or TAF tablets will be administered orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nucleos(t)ide Analog (NA)
Description: NA treatment that is either of ETV, TDF or TAF tablets will be administered orally.